Suraksha Diagnostics reported a net profit of ₹34.1 crore for FY26, achieving revenue of ₹300.7 crore. The company announced a dividend of ₹0.50 per share, however, they've noted an ongoing arbitration dispute in one of their subsidiaries.

Suraksha Diagnostics will be reviewing their financial results for the fiscal year 2025-26, including a potential dividend announcement, on May 21st, 2026. The trading window remains closed until 48 hours after the results are declared due to insider trading regulations.